American Century Companies’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.21M | Buy |
349,420
+40,668
| +13% | +$141K | ﹤0.01% | 2218 |
|
2025
Q1 | $809K | Buy |
308,752
+36,586
| +13% | +$95.9K | ﹤0.01% | 2328 |
|
2024
Q4 | $1.12M | Buy |
272,166
+51,499
| +23% | +$212K | ﹤0.01% | 2224 |
|
2024
Q3 | $1.56M | Buy |
220,667
+42,579
| +24% | +$301K | ﹤0.01% | 2055 |
|
2024
Q2 | $1.16M | Buy |
178,088
+28,894
| +19% | +$188K | ﹤0.01% | 2121 |
|
2024
Q1 | $1.24M | Buy |
149,194
+61,922
| +71% | +$514K | ﹤0.01% | 2057 |
|
2023
Q4 | $961K | Sell |
87,272
-297,264
| -77% | -$3.27M | ﹤0.01% | 2084 |
|
2023
Q3 | $3.23M | Buy |
384,536
+20,653
| +6% | +$174K | ﹤0.01% | 1501 |
|
2023
Q2 | $4.57M | Buy |
363,883
+123,502
| +51% | +$1.55M | ﹤0.01% | 1341 |
|
2023
Q1 | $3.95M | Buy |
240,381
+21,016
| +10% | +$345K | ﹤0.01% | 1348 |
|
2022
Q4 | $3.28M | Buy |
219,365
+330
| +0.2% | +$4.93K | ﹤0.01% | 1390 |
|
2022
Q3 | $4.9M | Sell |
219,035
-2,049
| -0.9% | -$45.8K | ﹤0.01% | 1118 |
|
2022
Q2 | $3.7M | Buy |
221,084
+16,201
| +8% | +$271K | ﹤0.01% | 1212 |
|
2022
Q1 | $6.13M | Buy |
204,883
+61
| +0% | +$1.83K | ﹤0.01% | 1057 |
|
2021
Q4 | $6.29M | Buy |
204,822
+6,755
| +3% | +$207K | ﹤0.01% | 1000 |
|
2021
Q3 | $6.25M | Buy |
198,067
+63
| +0% | +$1.99K | ﹤0.01% | 972 |
|
2021
Q2 | $7.25M | Buy |
198,004
+83,619
| +73% | +$3.06M | ﹤0.01% | 897 |
|
2021
Q1 | $3.95M | Sell |
114,385
-1,890
| -2% | -$65.3K | ﹤0.01% | 997 |
|
2020
Q4 | $4.83M | Sell |
116,275
-7,275
| -6% | -$302K | ﹤0.01% | 887 |
|
2020
Q3 | $5.26M | Buy |
+123,550
| New | +$5.26M | ﹤0.01% | 799 |
|